Long-term effects of asparaginase-associated pancreatitis.
Mette Tiedemann SkipperBirgitte Klug AlbertsenKjeld SchmiegelowLiv Andrés-JensenPublished in: Pediatric blood & cancer (2023)
Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.